Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of CDB-2914 for Emergency Contraception

ClinicalTrials.gov ID: NCT00411684

Public ClinicalTrials.gov record NCT00411684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 10:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open-Label, Single Arm, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of CDB-2914 as Emergency Contraception When Taken Between 48 Hours and 120 Hours of Unprotected Sex

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety and efficacy of CDB-2914 for preventing pregnancy when taken 3 to 5 days after unprotected sexual intercourse.

Study identification

NCT ID
NCT00411684
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
HRA Pharma
Industry
Enrollment
1,623 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2006 (Type not available)
Primary completion
Apr 8, 2008 (Actual)
Completion
Jun 5, 2009 (Actual)
Last update posted
Sep 21, 2021

2006 – 2009

United States locations

U.S. sites
17
U.S. states
15
U.S. cities
17
Facility City State ZIP Site status
Planned Parenthood of Mar Monte San Jose California 95126 —
Planned Parenthood of the Rocky Mountains Denver Colorado 80203 —
Planned Parenthood of Greater Miami, Palm Beach and Treasure Cost Miami Florida — —
Planned Parenthood of South Palm Beach, Pembroke Pines Pembroke Pines Florida — —
Planned Parenthood of Indiana Bloomington Indiana — —
Planned Parenthood of Greater Iowa Ames Iowa — —
Planned Parenthood of Maryland Baltimore Maryland 21201 —
Planned Parenthood League of Massachusetts Boston Massachusetts 02215 —
Planned Parenthood of Mid-Michigan Alliance Ann Arbor Michigan — —
Planned Parenthood of Minnesota Minneapolis Minnesota — —
Planned Parenthood of Greater Cleveland Cleveland Ohio — —
Planned Parenthood of Columbia-Willamette Portland Oregon 97206 —
Planned Parenthood of SE Philadelphia Philadelphia Pennsylvania — —
Planned Parenthood of the Texas Capital Region Austin Texas — —
Planned Parenthood of Houston and Southeast Texas Houston Texas 77004 —
Planned Parenthood Association of Utah Salt Lake City Utah — —
Planned Parenthood of Western Washington Seattle Washington 98122 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00411684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2021 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00411684 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →